z-logo
open-access-imgOpen Access
Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1
Author(s) -
Kaitao Zhao,
Zunhui Ke,
Hsiao Yun Hu,
Yahui Liu,
Aixin Li,
Rong Hua,
Fangteng Guo,
Junfeng Xiao,
Zhang Yu,
Luchun Duan,
Xin-Fu Yan,
YongGui Gao,
Bing Liu,
Yuchen Xia,
Yan Li
Publication year - 2021
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.00169-21
Subject(s) - n terminus , function (biology) , covid-19 , coronavirus , translation (biology) , c terminus , structural protein , biology , virology , peptide sequence , gene , microbiology and biotechnology , genetics , virus , medicine , amino acid , messenger rna , disease , infectious disease (medical specialty)
Nonstructural protein 1 (Nsp1) of severe acute respiratory syndrome coronaviruses (SARS-CoVs) is an important pathogenic factor that inhibits host protein translation by means of its C terminus. However, its N-terminal function remains elusive. Here, we determined the crystal structure of the N terminus (amino acids [aa] 11 to 125) of SARS-CoV-2 Nsp1 at a 1.25-Å resolution. Further functional assays showed that the N terminus of SARS-CoVs Nsp1 alone loses the ability to colocalize with ribosomes and inhibit protein translation. The C terminus of Nsp1 can colocalize with ribosomes, but its protein translation inhibition ability is significantly weakened. Interestingly, fusing the C terminus of Nsp1 with enhanced green fluorescent protein (EGFP) or other proteins in place of its N terminus restored the protein translation inhibitory ability to a level equivalent to that of full-length Nsp1. Thus, our results suggest that the N terminus of Nsp1 is able to stabilize the binding of the Nsp1 C terminus to ribosomes and act as a nonspecific barrier to block the mRNA channel, thus abrogating host mRNA translation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here